Navigation Links
ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:10/31/2007

EXTON, Pa., Oct. 31 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at 8:50 A.M. ET on Tuesday, November 6, 2007. The conference is being held at the New York Palace Hotel.

ViroPharma's presentation will be webcast live for investors through http://www.viropharma.com and available through November 20, 2007.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009).... 1 The new position of Executive ...otechnologies, Inc. has been taken up by Howard Go... than 30 years of experience creating and managing... will direct Microchip Biotechnologies, marketing,...operations as the company makes the transition fro...
(Date:12/1/2009)...Dec. 1 Galenea Corp. and Otsuka Ph... extension of their research and development colla...eases the collaboration term to seven years and br...$90 million. The companies have been working toge...ng and developing first-in-class therapies for sch...
(Date:12/1/2009)...swire-FirstCall/ -- Neogen Corporation (Nasdaq: N...Kits food safety business of San Diego, Calif.-bas... includes more than 50 test kits for food allergen..., Gen-Probe acquired the BioKits business throu...April 2009. Gen-Probe elected to divest the food s...
Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3Neogen Acquires Gen-Probe's BioKits Food Safety Business 2AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 1AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 2AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 3AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 4AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 5AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 6AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 61126 7VIVUS to Present at Lazard Capital Markets Healthcare Conference 6154 1VIVUS to Present at Lazard Capital Markets Healthcare Conference 6154 2Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 1Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 2Frost 26amp 3B Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market the Golden Standard in Patient Safety 61121 3
...ON, Oct. 16 The following is being,issued by Trus...ference call to discuss a new report from the,Amer...rica,s Health (TFAH),"Pandemic Influenza: Warning,...U.S. preparedness in treating and caring for child...ovides recommendations from AAP and TFAH for,how t...
....D. a noted Plastic,and Reconstructive Surgeon, is...l trial performing a minimally invasive breast rec... expansion system and liposuctioned,micro-fat graf...,lumpectomy, with or without radiation therapy. T... major, "open",surgery that requires extensive rec...
Other Medicine Technology:New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study 2
(Date:12/2/2009)...nables Personal Health Record Devices with Medical... PA (PRWEB) December 2, 2009 -- Perhaps the best m...wn medical records. With the advent of Person Heal...cal records is easier than ever. MyEMRChoice.com, ...company has added services that will populate exis...
(Date:12/2/2009)...ieves IBM Ready for LINUX designation and enhances...inframe and contemporary systems running Linux. ,...ber 2, 2009 -- eCube Systems, a leader in legacy e...unced that it has achieved the IBM Ready for LINUX...eware. This mark certifies NXTera has met compati...
(Date:12/2/2009)...FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPR...Health Care Conference today at 2:30 p.m. Eastern ...live and may be accessed through a link on the inv...probe.com . The webcast will be available for 30 d...,, Gen-Probe Incorporated is a global leader in...
(Date:12/2/2009)...ewswire/ -- Targeted breast ultrasound of suspicio..., reliable and cost-effective alternative to invas...the findings of two studies presented today at the...th America (RSNA). ,, "By performing high-quali...expensive and avoidable invasive diagnostic proced...
(Date:12/2/2009)...spicious areas of the breast, including lumps, is ... invasive biopsies for women under age 40, accordi...at the annual meeting of the Radiological Society ...uality breast ultrasound, we can reduce the number...ocedures in young women," said senior author Const...
Breaking Medicine News(10 mins):Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2
...affect younger men with clogged arteries leading t...to a research published in the current issue of Ps...// situation do not show any such tendencies, said...ply blood to the head, in men who reported having ...
...eading cause of accidental death for elderly peopl...as revealed that diabetics are four times more lik...rrently 150 million people are estimated to have t...g frail elderly nursing home residents, which incl...
...s for ears, which are done in a minimally invasive...he traditional way. Researchers from University of...earch finding // at the 109th Annual Meeting & OTO...mastoidectomy (a surgical removal of the mastoid a...
...ople on antiretroviral therapy has doubled to 1 mi...ia and Africa are two regions which are hit greatl...antiretroviral // treatment, it is still far less ...f those in Africa and 14% of those in Asia have ac...
...by physiological levels free radicals and antioxid...ve been well established following our improved un...rs // potential scope because of the fact that con...tation of antioxidants. Green tea consists of...
...r the threat posed by new virus-induced diseases l...ed institute has launched a course offering specia... // Biotechnology and Bioinformatics of the Univer...ended to provide qualified virologists to various ...
Other Medicine News:Health News:Protection against Alzheimer’s could be as simple as drinking green te 2Health News:Launch Of India’s First Virology Course At Pun 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: